
With a professional career that spans more than three decades in the energy, finance, and public health engineering industries, Steve Verschoor leverages those experiences to serve as the head of sales at GTSP Global, a Boise-based solar power energy company, which he co-founded in 2006. Additionally, Steve Verschoor co-founded Washington-based Molecular Testing Labs (MLT) that delivers diagnostic tools, testing, and vaccines for infectious diseases such as COVID-19.
Vaccines are critical in restricting the COVID-19 transmission and reducing the severity of the disease. Vaccination has reached millions of people in the United States, and the number is rising. The present rapid rise in cases involving the Delta variation is driven by low vaccination coverage in many areas, increasing the risk of even more worrisome variants emerging.
The COVID-19 vaccines licensed or authorized in the United States, including the Delta version, are very successful at preventing serious illness and fatality. However, they are not 100 percent effective, and some people who have been completely vaccinated can become infected (known as a breakthrough infection) and become sick. Nonetheless, vaccination offers the best protection against serious disease and death for everyone. Everyone above the age of 12 should get vaccinated as soon as possible, according to the Centers for Disease Control and Prevention.